April 14 (Reuters) - Danish drugmaker Novo Nordisk NOVOb.CO said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being distributed outside its authorized supply chain ...

Novo Nordisk stock rose rapidly early Friday after a study from the University of Oxford showed its diabetes and weight-loss drug, semaglutide, could lower the risk of developing dementia.